XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 45.17%1.59B | 45.17%1.59B | 100.79%1.93B | 99.79%1.33B | 22.66%849.9M | -10.26%1.1B | -10.26%1.1B | -11.13%960M | -39.13%663.6M | -48.61%692.9M |
-Cash and cash equivalents | 45.17%1.59B | 45.17%1.59B | 53.13%1.47B | 31.80%874.6M | 22.66%849.9M | -10.26%1.1B | -10.26%1.1B | -11.13%960M | -39.13%663.6M | -48.61%692.9M |
-Short-term investments | ---- | ---- | --457.6M | --451.2M | ---- | ---- | ---- | ---- | ---- | ---- |
Receivables | 4.51%3.09B | 4.51%3.09B | 7.98%3.39B | 7.30%3.43B | 12.81%2.94B | 6.36%2.96B | 6.36%2.96B | 9.59%3.14B | 16.01%3.2B | 7.25%2.61B |
-Accounts receivable | 4.51%3.09B | 4.51%3.09B | 7.98%3.39B | 7.30%3.43B | 12.81%2.94B | 6.36%2.96B | 6.36%2.96B | 9.59%3.14B | 16.01%3.2B | 7.25%2.61B |
Inventory | -8.39%1.97B | -8.39%1.97B | -7.23%2.03B | -6.46%2.2B | 1.66%2.38B | 7.94%2.15B | 7.94%2.15B | 12.45%2.19B | 24.85%2.36B | 25.18%2.34B |
Other current assets | 3.05%686M | 3.05%686M | 72.28%745.3M | 64.85%751.4M | 65.39%714.8M | 73.00%665.7M | 73.00%665.7M | 7.53%432.6M | 16.90%455.8M | 13.74%432.2M |
Total current assets | 6.81%7.34B | 6.81%7.34B | 20.41%8.1B | 15.57%7.71B | 13.37%6.89B | 7.69%6.87B | 7.69%6.87B | 6.79%6.73B | 8.98%6.68B | 0.73%6.07B |
Non current assets | ||||||||||
Net PPE | 14.24%2.02B | 14.24%2.02B | 13.23%1.91B | 10.46%1.83B | 13.02%1.79B | 15.37%1.77B | 15.37%1.77B | 17.58%1.68B | 16.05%1.65B | 11.26%1.58B |
-Gross PPE | 10.12%4.21B | 10.12%4.21B | ---- | ---- | ---- | 10.80%3.82B | 10.80%3.82B | ---- | ---- | ---- |
-Accumulated depreciation | -6.56%-2.18B | -6.56%-2.18B | ---- | ---- | ---- | -7.12%-2.05B | -7.12%-2.05B | ---- | ---- | ---- |
Goodwill and other intangible assets | -1.04%9.44B | -1.04%9.44B | 5.76%9.58B | 2.99%9.41B | 7.96%9.45B | 8.75%9.54B | 8.75%9.54B | 5.17%9.06B | 4.55%9.14B | -0.16%8.75B |
-Goodwill | 0.53%6.13B | 0.53%6.13B | 8.66%6.21B | 5.40%6.06B | 9.73%6.06B | 10.75%6.1B | 10.75%6.1B | 6.49%5.72B | 5.33%5.75B | 0.48%5.52B |
-Other intangible assets | -3.83%3.31B | -3.83%3.31B | 0.81%3.36B | -1.10%3.35B | 4.94%3.39B | 5.39%3.44B | 5.39%3.44B | 2.98%3.34B | 3.24%3.39B | -1.22%3.23B |
Other non current assets | 11.00%1.35B | 11.00%1.35B | -8.16%1.32B | -13.35%1.25B | -18.25%1.22B | -13.15%1.21B | -13.15%1.21B | 2.76%1.44B | 3.58%1.44B | 4.93%1.49B |
Total non current assets | 2.29%12.81B | 2.29%12.81B | 5.16%12.8B | 2.07%12.49B | 5.34%12.45B | 7.00%12.52B | 7.00%12.52B | 6.43%12.18B | 5.85%12.23B | 1.86%11.82B |
Total assets | 3.89%20.15B | 3.89%20.15B | 10.58%20.9B | 6.84%20.2B | 8.07%19.34B | 7.25%19.39B | 7.25%19.39B | 6.56%18.9B | 6.93%18.91B | 1.48%17.9B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 6.06%2.15B | 6.06%2.15B | 4.85%2.19B | 0.15%2.18B | 2.33%2.01B | -3.17%2.03B | -3.17%2.03B | 1.55%2.09B | 8.83%2.18B | 1.60%1.96B |
-accounts payable | 6.06%2.15B | 6.06%2.15B | 4.85%2.19B | 0.15%2.18B | 2.33%2.01B | -3.17%2.03B | -3.17%2.03B | 1.55%2.09B | 8.83%2.18B | 1.60%1.96B |
Current accrued expenses | 5.91%2.79B | 5.91%2.79B | 26.82%2.86B | 21.39%2.96B | 27.39%2.76B | 31.34%2.63B | 31.34%2.63B | 15.42%2.26B | 15.13%2.44B | 13.54%2.17B |
Current debt and capital lease obligation | -43.61%452.2M | -43.61%452.2M | 173.39%952.2M | 73.03%952M | 159.00%902.1M | -23.48%801.9M | -23.48%801.9M | -66.83%348.3M | -47.59%550.2M | -0.60%348.3M |
-Current debt | -43.61%452.2M | -43.61%452.2M | 173.39%952.2M | 73.03%952M | 159.00%902.1M | -23.48%801.9M | -23.48%801.9M | -66.83%348.3M | -47.59%550.2M | -0.60%348.3M |
Current liabilities | 0.25%6.07B | 0.25%6.07B | 27.13%6.63B | 17.86%6.59B | 26.30%6.1B | 6.45%6.05B | 6.45%6.05B | -5.97%5.21B | -0.66%5.59B | 5.16%4.83B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 8.55%4.32B | 8.55%4.32B | -3.56%4.32B | -3.58%4.32B | -11.23%3.98B | 5.00%3.98B | 5.00%3.98B | 18.19%4.48B | 18.22%4.48B | -0.24%4.48B |
-Long term debt | 8.55%4.32B | 8.55%4.32B | -3.56%4.32B | -3.58%4.32B | -11.23%3.98B | 5.00%3.98B | 5.00%3.98B | 18.19%4.48B | 18.22%4.48B | -0.24%4.48B |
Non current deferred liabilities | -16.64%586.6M | -16.64%586.6M | -2.56%678.3M | 0.25%695.3M | 6.54%677.9M | 3.47%703.7M | 3.47%703.7M | 8.92%696.1M | 12.51%693.6M | 8.45%636.3M |
Employee benefits | -5.86%561.9M | -5.86%561.9M | -7.93%575.5M | -12.70%594M | -10.77%602.2M | -10.51%596.9M | -10.51%596.9M | -14.48%625.1M | -10.14%680.4M | -13.57%674.9M |
Other non current liabilities | 7.81%1.12B | 7.81%1.12B | -8.52%1.09B | -12.80%1.03B | -12.23%1.07B | -9.64%1.04B | -9.64%1.04B | 1.94%1.19B | 3.02%1.19B | 4.54%1.22B |
Total non current liabilities | 4.26%6.59B | 4.26%6.59B | -4.69%6.66B | -5.64%6.64B | -9.74%6.33B | 0.51%6.32B | 0.51%6.32B | 10.48%6.99B | 11.49%7.04B | -0.20%7.01B |
Total liabilities | 2.30%12.66B | 2.30%12.66B | 8.90%13.29B | 4.77%13.23B | 4.96%12.43B | 3.33%12.37B | 3.33%12.37B | 2.79%12.2B | 5.76%12.63B | 1.92%11.84B |
Shareholders'equity | ||||||||||
Share capital | -1.07%249M | -1.07%249M | -1.03%249.7M | -0.95%250.4M | -0.51%251.2M | -0.63%251.7M | -0.63%251.7M | -0.98%252.3M | -1.33%252.8M | -2.25%252.5M |
-common stock | -1.07%249M | -1.07%249M | -1.03%249.7M | -0.95%250.4M | -0.51%251.2M | -0.63%251.7M | -0.63%251.7M | -0.98%252.3M | -1.33%252.8M | -2.25%252.5M |
Retained earnings | 7.21%9.79B | 7.21%9.79B | 8.10%9.7B | 8.87%9.19B | 11.00%9.1B | 9.77%9.13B | 9.77%9.13B | 7.82%8.97B | 5.52%8.45B | 1.28%8.2B |
Paid-in capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 93.39%23.4M | ---- |
Less: Treasury stock | -0.01%1.72B | -0.01%1.72B | 0.00%1.72B | 0.00%1.72B | 0.00%1.72B | 0.00%1.72B | 0.00%1.72B | 0.00%1.72B | 0.00%1.72B | 0.00%1.72B |
Gains losses not affecting retained earnings | -28.82%-864.1M | -28.82%-864.1M | 22.58%-636.4M | -4.71%-778.4M | -6.72%-746.3M | 12.45%-670.8M | 12.45%-670.8M | 17.59%-822M | 10.34%-743.4M | -9.44%-699.3M |
Total stockholders'equity | 6.61%7.46B | 6.61%7.46B | 13.61%7.59B | 11.00%6.95B | 14.14%6.89B | 14.89%7B | 14.89%7B | 14.06%6.68B | 9.35%6.26B | 0.63%6.04B |
Noncontrolling interests | 35.32%29.5M | 35.32%29.5M | 22.58%22.8M | 10.33%20.3M | 15.93%21.1M | 31.33%21.8M | 31.33%21.8M | 84.16%18.6M | 16.46%18.4M | 1.68%18.2M |
Total equity | 6.70%7.49B | 6.70%7.49B | 13.64%7.61B | 11.00%6.97B | 14.15%6.91B | 14.93%7.02B | 14.93%7.02B | 14.18%6.7B | 9.37%6.28B | 0.63%6.05B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |